Circulation Research, Vol 74, 912-919, Copyright © 1994 by American Heart Association

ARTICLES

In vivo characterization of vasodilating muscarinic-receptor subtypes in humans

TA Bruning, MG Hendriks, PC Chang, EA Kuypers and PA van Zwieten
Department of Nephrology, University Hospital Leiden, The Netherlands.

The role of muscarinic (M)-receptor subtypes in the regulation of vascular tone has not yet been defined in humans. To analyze the role of M-receptor subtypes in the forearm resistance vasculature of normotensive volunteers (n = 20), we infused acetylcholine (ACh) and methacholine (MCh) in the presence of saline and the antagonists atropine (nonselective), pirenzepine (M1 selective), and AF-DX 116 (M2 selective), using automated R-wave-triggered venous occlusion plethysmography. Schild analysis was applied by calculating plasma concentrations of the infused compounds and determining EC50 values. ACh and MCh both caused dose-dependent vasodilation, with EC50 values of 537 and 52 nmol/L, respectively. The apparent 10-fold higher potency of MCh compared with ACh may be explained by rapid degradation of ACh in plasma. The concentration-response curve of MCh was shifted to the right by atropine, pirenzepine, and AF-DX 116, with apparent pA2 values of 8.03 +/- 0.03, 6.71 +/- 0.08, and 5.32 +/- 0.05, respectively, and slopes not different from unity. The present technique enabled us to perform M-receptor characterization by Schild analysis in humans. The affinity constants and rank order of potency--atropine > pirenzepine > AF-DX 116-suggest that cholinergic vasodilation in this vascular bed is predominantly mediated by the M3-receptor subtype. The EC50 value of MCh and the pA2 values of pirenzepine and AF-DX 116 are comparable to values reported for in vitro experiments.

This article has been cited by other articles:

				G. Murdolo, M. Sjostrand, L. Strindberg, S. Gudbjornsdottir, L. Lind, P. Lonnroth, and P.-A. Jansson Effects of Intrabrachial Metacholine Infusion on Muscle Capillary Recruitment and Forearm Glucose Uptake during Physiological Hyperinsulinemia in Obese, Insulin-Resistant Individuals J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2764 - 2773. [Abstract] [Full Text] [PDF]

				M. L. H. Honing, P. Smits, P. J. Morrison, J. C. Burnett Jr, and T. J. Rabelink C-Type Natriuretic Peptide-Induced Vasodilation Is Dependent On Hyperpolarization in Human Forearm Resistance Vessels Hypertension, April 1, 2001; 37(4): 1179 - 1183. [Abstract] [Full Text] [PDF]

				J. J. Saris, M. A. van Dijk, I. Kroon, M. A. D. H. Schalekamp, and A. H. J. Danser Functional Importance of Angiotensin-Converting Enzyme-Dependent In Situ Angiotensin II Generation in the Human Forearm Hypertension, March 1, 2000; 35(3): 764 - 768. [Abstract] [Full Text] [PDF]

				T. V. Lewis, A. M. Dart, J. P. F. Chin-Dusting, and B. A. Kingwell Exercise Training Increases Basal Nitric Oxide Production From the Forearm in Hypercholesterolemic Patients Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2782 - 2787. [Abstract] [Full Text] [PDF]

				R. W. Brock, M. E. Tschakovsky, J. K. Shoemaker, J. R. Halliwill, M. J. Joyner, and R. L. Hughson Effects of acetylcholine and nitric oxide on forearm blood flow at rest and after a single muscle contraction J Appl Physiol, December 1, 1998; 85(6): 2249 - 2254. [Abstract] [Full Text] [PDF]

				C. Cardillo, C. M. Kilcoyne, A. A. Quyyumi, R. O. Cannon III, and J. A. Panza Selective Defect in Nitric Oxide Synthesis May Explain the Impaired Endothelium-Dependent Vasodilation in Patients With Essential Hypertension Circulation, March 10, 1998; 97(9): 851 - 856. [Abstract] [Full Text] [PDF]

				T. A Bruning, M. J.B Kemme, P. C Chang, Y. Muizert, and P. A van Zwieten Calculation of plasma concentrations of intra-arterially infused compounds in forearm plethysmography Cardiovasc Res, January 1, 1998; 37(1): 210 - 215. [Abstract] [Full Text] [PDF]

				D. B. Hoover and D. A. Neely Differentiation of Muscarinic Receptors Mediating Negative Chronotropic and Vasoconstrictor Responses to Acetylcholine in Isolated Rat Hearts J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1337 - 1344. [Abstract] [Full Text]

				M. Kelm, M. Preik, D. J. Hafner, and B. E. Strauer Evidence for a Multifactorial Process Involved in the Impaired Flow Response to Nitric Oxide in Hypertensive Patients With Endothelial Dysfunction Hypertension, March 1, 1996; 27(3): 346 - 353. [Abstract] [Full Text]

				R. Joannides, V. Richard, W. E. Haefeli, L. Linder, T. F. Luscher, and C. Thuillez Role of Basal and Stimulated Release of Nitric Oxide in the Regulation of Radial Artery Caliber in Humans Hypertension, August 1, 1995; 26(2): 327 - 331. [Abstract] [Full Text]

				T. A. Bruning, P. C. Chang, M. G.C. Hendriks, P. Vermeij, M. Pfaffendorf, and P. A. van Zwieten In Vivo Characterization of Muscarinic Receptor Subtypes That Mediate Vasodilatation in Patients With Essential Hypertension Hypertension, July 1, 1995; 26(1): 70 - 77. [Abstract] [Full Text]